Page 3 - Tarsu Form News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tarsus Announces Proposed $100 0 Million Underwritten Public Offering of Shares of its Common Stock

IRVINE, Calif., July 31, 2023 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.

North carolinaUnited statesNew yorkDavid nakasoneAdrienne kempGoldman sachs coCorporate communicationsExchange commissionSyndicate prospectus departmentGuggenheim securitiesCompany or tarsusEquity syndicate departmentTarsus pharmaceuticals incProspectus departmentOppenheimer coBofa securities

FDA Approves XDEMVY™ (lotilaner ophthalmic solution) 0 25% for the treatment of Demodex blepharitis

XDEMVY is the first and only approved therapeutic for Demodex blepharitis, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S. XDEMVY targets the.

United statesAdrienne kempChristopher starrBobak azamianDavid nakasoneSelina mcgeeTarsus pharmaceuticals incCornea fellowship program at weill cornell medicineExchange commissionCompany investor relationsDrug administrationCorporate communicationsChief executive officerAssociate professorRefractive surgeryOphthalmic education

Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer

IRVINE, Calif., April 24, 2023 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,. | June 18, 2023

United statesAdrienne kempDavid nakasoneLeo greensteinBobak azamianExchange commissionHyperion therapeutics incUs food drug administrationTarsus pharmaceuticals incCorporate communicationsGlobal blood therapeutics incJeff farrowChief financial officerChief strategy officerGlobal blood therapeuticsHyperion therapeutics

Tarsus Pharmaceuticals (TARS) Added to NASDAQ Biotechnology Index

Tarsus Pharmaceuticals (TARS) Added to NASDAQ Biotechnology Index
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Adrienne kempsrExchange commissionUs food drug administrationCorporate communicationsTarsus pharmaceuticals incBiotechnology index fundWall streetNasdaq stockIndex fundTarsus pharmaceuticalsInc tarsus pharmaceuticalsNew drug applicationDrug administrationMeibomian gland diseaseLooking statementsstatementsTarsu form

Tarsus Pharmaceuticals (TARS) Reports Positive Topline Data from Phase 1b Callisto Trial, Initiates Phase 2a Carpo Human Tick Kill Trial

Tarsus Pharmaceuticals (TARS) Reports Positive Topline Data from Phase 1b Callisto Trial, Initiates Phase 2a Carpo Human Tick Kill Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid nakasoneAdrienne kempCenters for diseaseTarsus pharmaceuticals incDrug administrationExchange commissionUs food drug administrationCorporate communicationsCarpo phaseChief medical officerDisease controlTarsus pharmaceuticalsNew drug applicationMeibomian gland diseaseTarsu form